BRAIN App program to support communication and engagement for people with dementia
Official title: The BRAIN App (Phase 2 SBIR): Building Relationships Using Artificial Intelligence and Nostalgia
Run by Hopeful Aging · NCT06298474 · Data updated 2026-11-12
This program tests whether the BRAIN App can improve communication, mood, and quality of life for people aged 65 and older with dementia living in long-term care, with training and support for family members and staff.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Hopeful Aging Industry-sponsored |
| Locations | 1 site (Winchester, Massachusetts) |
| Status | Recruiting |
| Started | May 15, 2025 |
| Main results expected | November 30, 2026 |
| Study ends | November 30, 2026 |
| Registry record updated | September 15, 2026 |
| Trial ID | NCT06298474 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people aged 65 or older with a clinical diagnosis of dementia who can speak conversational English and live in one of the participating long-term care facilities.
✕Probably not a fit
Patients who are completely unable to communicate verbally, have serious uncorrected visual or hearing impairments, or show signs of rapid decline over the past three months are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The project delivers a digital Cognitive Stimulation Therapy program via the BRAIN App to people living with dementia in nursing homes and assisted living facilities. A total of 120 residents (aged 65+) across eight long-term care sites will be split into experimental (n=60) and control (n=60) groups and measured before and after the intervention using a quasi-experimental pre-post design. Family members at experimental sites will use the app twice per month and staff will complete BRAIN training modules and use the platform to support sessions and report usability feedback. Key outcomes include resident quality of life, responsive behaviors, and relationship functioning between residents, professional care partners, and family members.
Why it matters
Potential benefit: If successful, the app could improve quality of life, reduce behavioral symptoms, and strengthen relationships between people living with dementia and their caregivers.
How similar studies have gone: Cognitive Stimulation Therapy has shown improvements in cognition and quality of life in prior trials, but delivering CST via a dedicated app is relatively novel though Phase I pilot work informed this Phase II effort.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 65+ years old * Clinical diagnosis of dementia (any type) * Able to speak conversational English Exclusion Criteria: * Completely unable to communicate verbally * Serious visual or hearing impairments * Signs of rapid decline over the last three months (based upon staff report)
Where it's running
-
Hopeful Aging
Winchester, Massachusetts, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hyperspectral retinal imaging to detect Alzheimer’s and other neurodegenerative changes
This project will test whether a special retinal camera that scans many wavelengths of light can detect signs of Alzheimer’s and other neurodegenerative diseases in people with dementia or at risk.
-
Predicting disease progression in dementia using biomarkers and modeling
This study is trying to create a tool that helps predict how dementia will progress in people with mild cognitive impairment and different types of dementia, like Alzheimer's and Lewy Body Disease, by looking at brain scans, body fluids, and mental tests.
-
Connecting Through Music for people with dementia
The trial tests a music-based program led by volunteers or staff to help residents with dementia in long-term care facilities, aiming to ease behavioral symptoms and improve caregiving efficiency.
-
Blood biomarker cohort for memory disorders in older adults
This observational cohort will collect blood samples and brain imaging data from adults 50+ with memory disorders and a small group of healthy young adults to help find biomarkers.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
Norms for a Voice-Based Digital Cognitive Test Across Ages
This study tests a voice-enabled digital cognitive test to establish normal scores for adults aged 18–100.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.